Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.
Morra F, Merolla F, Damia G, Ricci F, Varricchio S, Ilardi G, Arenare L, Califano D, Napolitano V, Fruscio R, Melillo RM, Palazzo L, Celetti A. Morra F, et al. Among authors: melillo rm. J Exp Clin Cancer Res. 2022 Aug 13;41(1):245. doi: 10.1186/s13046-022-02459-2. J Exp Clin Cancer Res. 2022. PMID: 35964058 Free PMC article.
Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
Celetti A, Testa D, Staibano S, Merolla F, Guarino V, Castellone MD, Iovine R, Mansueto G, Somma P, De Rosa G, Galli V, Melillo RM, Santoro M. Celetti A, et al. Among authors: melillo rm. Clin Cancer Res. 2005 Nov 15;11(22):8019-27. doi: 10.1158/1078-0432.CCR-05-0641. Clin Cancer Res. 2005. PMID: 16299231
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome.
Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, Guarino V, Castellone MD, Di Benedetto M, Galli V, Motta S, Melillo RM, De Rosa G, Santoro M, Celetti A. Staibano S, et al. Among authors: melillo rm. Br J Cancer. 2007 Dec 3;97(11):1545-51. doi: 10.1038/sj.bjc.6604070. Epub 2007 Nov 6. Br J Cancer. 2007. PMID: 17987038 Free PMC article.
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.
Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R. Collina F, et al. Among authors: melillo rm. Cancers (Basel). 2019 Jun 7;11(6):785. doi: 10.3390/cancers11060785. Cancers (Basel). 2019. PMID: 31181609 Free PMC article.
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells.
Liotti F, Kumar N, Prevete N, Marotta M, Sorriento D, Ieranò C, Ronchi A, Marino FZ, Moretti S, Colella R, Puxeddu E, Paladino S, Kano Y, Ohh M, Scala S, Melillo RM. Liotti F, et al. Among authors: melillo rm. J Exp Clin Cancer Res. 2021 Jan 7;40(1):22. doi: 10.1186/s13046-020-01818-1. J Exp Clin Cancer Res. 2021. PMID: 33413561 Free PMC article.
104 results